Briefing Book - DAXAS (roflumilast) Forest Research Institute Inc. / ITT / /
Currency
pence / /
Event
FDA Phase / /
Facility
Plaza V Jersey City / /
MedicalCondition
RATIONALE FOR USE OF ROFLUMILAST IN COPD / Pivotal COPD / Previous and Concurrent Diseases / COPD / CONCLUSIONS FROM THE PIVOTAL ROFLUMILAST COPD STUDIES / COPD BACKGROUND / /
Organization
FDA / Pulmonary-Allergy Drugs Advisory Committee / Forest Research Institute / /